610 related articles for article (PubMed ID: 19890833)
21. Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy.
Goda JS; Gospodarowicz M; Pintilie M; Wells W; Hodgson DC; Sun A; Crump M; Tsang RW
Cancer; 2010 Aug; 116(16):3815-24. PubMed ID: 20564130
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous B-cell lymphoma: pathological spectrum and clinical outcome in 51 consecutive patients.
Sah A; Barrans SL; Parapia LA; Jack AS; Owen RG
Am J Hematol; 2004 Apr; 75(4):195-9. PubMed ID: 15054808
[TBL] [Abstract][Full Text] [Related]
23. Nodal monocytoid B-cell lymphoma (nodal marginal-zone B-cell lymphoma).
Nathwani BN; Drachenberg MR; Hernandez AM; Levine AM; Sheibani K
Semin Hematol; 1999 Apr; 36(2):128-38. PubMed ID: 10319381
[TBL] [Abstract][Full Text] [Related]
24. Ophthalmic lymphoma: epidemiology and pathogenesis.
Sjö LD
Acta Ophthalmol; 2009 Feb; 87 Thesis 1():1-20. PubMed ID: 19178392
[TBL] [Abstract][Full Text] [Related]
25. Radiotherapy for 41 patients with stages I and II MALT lymphoma: a retrospective study.
Yamashita H; Nakagawa K; Asari T; Murakami N; Igaki H; Ohtomo K
Radiother Oncol; 2008 Jun; 87(3):412-7. PubMed ID: 18423914
[TBL] [Abstract][Full Text] [Related]
26. More than a third of non-gastric malt lymphomas are disseminated at diagnosis: a single center survey.
Sretenovic M; Colovic M; Jankovic G; Suvajdzic N; Mihaljevic B; Colovic N; Todorovic M; Atkinson HD
Eur J Haematol; 2009 May; 82(5):373-80. PubMed ID: 19141118
[TBL] [Abstract][Full Text] [Related]
27. Beta-2-microglobulin levels in patients with extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type: a retrospective analysis.
Penz MZ; Fiebiger WC; Valencak JB; Osterreicher C; Ba-Ssalamah A; Formanek M; Brodowic T; Chott A; Raderer M
Anticancer Res; 2001; 21(4B):3049-52. PubMed ID: 11712809
[TBL] [Abstract][Full Text] [Related]
28. Orbital marginal zone B-cell lymphoma of MALT: radiotherapy results and clinical behavior.
Suh CO; Shim SJ; Lee SW; Yang WI; Lee SY; Hahn JS
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):228-33. PubMed ID: 16503386
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of anatomic subsites: results of radiation therapy for 66 patients with localized orbital marginal zone B cell lymphoma.
Nam H; Ahn YC; Kim YD; Ko Y; Kim WS
Radiother Oncol; 2009 Feb; 90(2):236-41. PubMed ID: 18950885
[TBL] [Abstract][Full Text] [Related]
30. Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients.
Servitje O; Muniesa C; Benavente Y; Monsálvez V; Garcia-Muret MP; Gallardo F; Domingo-Domenech E; Lucas A; Climent F; Rodriguez-Peralto JL; Ortiz-Romero PL; Sandoval J; Pujol RM; Estrach MT
J Am Acad Dermatol; 2013 Sep; 69(3):357-65. PubMed ID: 23796549
[TBL] [Abstract][Full Text] [Related]
31. Mantle cell lymphoma in the ocular adnexal region.
Looi A; Gascoyne RD; Chhanabhai M; Connors JM; Rootman J; White VA
Ophthalmology; 2005 Jan; 112(1):114-9. PubMed ID: 15629830
[TBL] [Abstract][Full Text] [Related]
32. Effective palliation by low dose local radiotherapy for recurrent and/or chemotherapy refractory non-follicular lymphoma patients.
Haas RL; Poortmans P; de Jong D; Verheij M; van der Hulst M; de Boer JP; Bartelink H
Eur J Cancer; 2005 Aug; 41(12):1724-30. PubMed ID: 16039113
[TBL] [Abstract][Full Text] [Related]
33. Ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy.
Ejima Y; Sasaki R; Okamoto Y; Maruta T; Azumi A; Hayashi Y; Demizu Y; Ota Y; Soejima T; Sugimura K
Radiother Oncol; 2006 Jan; 78(1):6-9. PubMed ID: 16359744
[TBL] [Abstract][Full Text] [Related]
34. Treatment and survival of 38 female breast lymphomas: a population-based study with clinical and pathological reviews.
Kuper-Hommel MJ; Snijder S; Janssen-Heijnen ML; Vrints LW; Kluin-Nelemans JC; Coebergh JW; Noordijk EM; Vreugdenhil G
Ann Hematol; 2003 Jul; 82(7):397-404. PubMed ID: 12764549
[TBL] [Abstract][Full Text] [Related]
35. Orbital lymphoproliferative tumors: analysis of clinical features and systemic involvement in 160 cases.
Demirci H; Shields CL; Karatza EC; Shields JA
Ophthalmology; 2008 Sep; 115(9):1626-31, 1631.e1-3. PubMed ID: 18440641
[TBL] [Abstract][Full Text] [Related]
36. Multicenter randomized phase II study of weekly or twice-weekly bortezomib plus rituximab in patients with relapsed or refractory follicular or marginal-zone B-cell lymphoma.
de Vos S; Goy A; Dakhil SR; Saleh MN; McLaughlin P; Belt R; Flowers CR; Knapp M; Hart L; Patel-Donnelly D; Glenn M; Gregory SA; Holladay C; Zhang T; Boral AL
J Clin Oncol; 2009 Oct; 27(30):5023-30. PubMed ID: 19770386
[TBL] [Abstract][Full Text] [Related]
37. Lymphoproliferative diseases of the ocular adnexa in Korea.
Oh DE; Kim YD
Arch Ophthalmol; 2007 Dec; 125(12):1668-73. PubMed ID: 18071120
[TBL] [Abstract][Full Text] [Related]
38. Ophthalmologic and intraocular non-Hodgkin's lymphoma: a large single centre study of initial characteristics, natural history, and prognostic factors.
Meunier J; Lumbroso-Le Rouic L; Vincent-Salomon A; Dendale R; Asselain B; Arnaud P; Fourquet A; Desjardins L; Plancher C; Validire P; Chaoui D; Lévy C; Decaudin D
Hematol Oncol; 2004 Dec; 22(4):143-58. PubMed ID: 16134191
[TBL] [Abstract][Full Text] [Related]
39. Isolated lymph node relapse of epithelial ovarian carcinoma: outcomes and prognostic factors.
Blanchard P; Plantade A; Pagès C; Afchain P; Louvet C; Tournigand C; de Gramont A
Gynecol Oncol; 2007 Jan; 104(1):41-5. PubMed ID: 16952391
[TBL] [Abstract][Full Text] [Related]
40. [Clinicopathologic features of primary thyroid lymphoma].
Zhou SY; Huang DZ; Shi YK; He XH; Wu YH; Li YX
Ai Zheng; 2005 Jan; 24(1):95-8. PubMed ID: 15642210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
